These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. The effect of dexamethasone on the 24-hour profiles of adrenocorticotropin and cortisol in Cushing's syndrome. Refetoff S; Van Cauter E; Fang VS; Laderman C; Graybeal ML; Landau RL J Clin Endocrinol Metab; 1985 Mar; 60(3):527-35. PubMed ID: 2982900 [TBL] [Abstract][Full Text] [Related]
25. Evaluation and treatment of Cushing's syndrome. Nieman LK; Ilias I Am J Med; 2005 Dec; 118(12):1340-6. PubMed ID: 16378774 [TBL] [Abstract][Full Text] [Related]
26. Effect of single doses of dexamethasone and adrenocorticotrop hormone on serum bone markers in healthy subjects and in patients with adrenal incidentalomas and Cushing's syndrome. Majnik J; Szücs N; Patócs A; Tóth M; Balogh K; Varga I; Gláz E; Rácz K J Endocrinol Invest; 2004 Sep; 27(8):747-53. PubMed ID: 15636428 [TBL] [Abstract][Full Text] [Related]
27. Characterization of adrenal autonomy in Cushing's syndrome: a comparison between in vivo and in vitro responsiveness of the adrenal gland. Lamberts SW; Zuiderwijk J; Uitterlinden P; Blijd JJ; Bruining HA; de Jong FH J Clin Endocrinol Metab; 1990 Jan; 70(1):192-9. PubMed ID: 2152930 [TBL] [Abstract][Full Text] [Related]
28. FK 33-824, a met-enkephalin analog, blocks corticotropin-releasing hormone-induced adrenocorticotropin secretion in normal subjects but not in patients with Cushing's disease. Allolio B; Deuss U; Kaulen D; Leonhardt U; Kallabis D; Hamel E; Winkelmann W J Clin Endocrinol Metab; 1986 Dec; 63(6):1427-31. PubMed ID: 3023423 [TBL] [Abstract][Full Text] [Related]
29. The ovine corticotropin-releasing hormone (CRH) stimulation test is superior to the human CRH stimulation test for the diagnosis of Cushing's disease. Nieman LK; Cutler GB; Oldfield EH; Loriaux DL; Chrousos GP J Clin Endocrinol Metab; 1989 Jul; 69(1):165-9. PubMed ID: 2543689 [TBL] [Abstract][Full Text] [Related]
30. Cerebrospinal fluid immunoreactive corticotropin-releasing hormone and adrenocorticotropin secretion in Cushing's disease and major depression: potential clinical implications. Kling MA; Roy A; Doran AR; Calabrese JR; Rubinow DR; Whitfield HJ; May C; Post RM; Chrousos GP; Gold PW J Clin Endocrinol Metab; 1991 Feb; 72(2):260-71. PubMed ID: 1846869 [TBL] [Abstract][Full Text] [Related]
31. A reappraisal of the ovine corticotropin-releasing hormone stimulation test in the differential diagnosis of Cushing's syndrome: a comparison with the standard high-dose dexamethasone suppression test. Lee TI; Lin SY; Won JG; Tang KT; Jap TS; Kwok CF; Lin HD Zhonghua Yi Xue Za Zhi (Taipei); 2002 Oct; 65(10):474-82. PubMed ID: 12523812 [TBL] [Abstract][Full Text] [Related]
32. [Evaluation of the accuracy of inferior petrosal sinus sampling in the differential diagnosis of ACTH-dependent Cushing's syndrome]. Tóth M; Vajda Z; Görömbey Z; Molnár F; Major L; Toke J; Szabolcs I; Szücs N; Kovács L; Kiss R; Czirják S; Füto L; Gláz E; Góth M; Rácz K Orv Hetil; 2007 May; 148(18):843-7. PubMed ID: 17468067 [TBL] [Abstract][Full Text] [Related]
33. [OSTEOPOROSIS IN DISEASES OF THE HYPOPHYSO-ADRENAL AXIS]. SERRAPERALBA A Rev Esp Reum Enferm Osteoartic; 1963 Oct; 10():298-306. PubMed ID: 14160847 [No Abstract] [Full Text] [Related]
34. An uncommon cause of Cushing's syndrome in a 70-year-old man. Cheung KK; So WY; Kong AP; Ma RC; Lee KF; Chow FC Hong Kong Med J; 2014 Aug; 20(4):335-8. PubMed ID: 25104006 [TBL] [Abstract][Full Text] [Related]
35. The corticotropin-releasing factor stimulation test. An aid in the evaluation of patients with Cushing's syndrome. Chrousos GP; Schulte HM; Oldfield EH; Gold PW; Cutler GB; Loriaux DL N Engl J Med; 1984 Mar; 310(10):622-6. PubMed ID: 6319991 [TBL] [Abstract][Full Text] [Related]
36. Residual adrenocortical function after bilateral adrenalectomy for pituitary-dependent Cushing's syndrome. Kemink L; Hermus A; Pieters G; Benraad T; Smals A; Kloppenborg P J Clin Endocrinol Metab; 1992 Nov; 75(5):1211-4. PubMed ID: 1331164 [TBL] [Abstract][Full Text] [Related]
37. ATR-101, a selective ACAT1 inhibitor, decreases ACTH-stimulated cortisol concentrations in dogs with naturally occurring Cushing's syndrome. Langlois DK; Fritz MC; Schall WD; Bari Olivier N; Smedley RC; Pearson PG; Bailie MB; Hunt SW BMC Endocr Disord; 2018 May; 18(1):24. PubMed ID: 29720169 [TBL] [Abstract][Full Text] [Related]
38. Adrenocorticotropic hormone-independent Cushing's syndrome. Bourdeau I; Lampron A; Costa MH; Tadjine M; Lacroix A Curr Opin Endocrinol Diabetes Obes; 2007 Jun; 14(3):219-25. PubMed ID: 17940443 [TBL] [Abstract][Full Text] [Related]
39. CRH in Cushing's syndrome. Müller OA; Stalla GK; von Werder K Horm Metab Res Suppl; 1987; 16():51-8. PubMed ID: 2832289 [TBL] [Abstract][Full Text] [Related]
40. Ectopic Cushing's syndrome due to concurrent corticotropin-releasing hormone (CRH) and adrenocorticotropic hormone (ACTH) secreted by malignant gastrinoma. Park SY; Rhee Y; Youn JC; Park YN; Lee S; Kim DM; Song SY; Lim SK Exp Clin Endocrinol Diabetes; 2007 Jan; 115(1):13-6. PubMed ID: 17286228 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]